Eye Patch Therapy for Central Serous Retinopathy (CSR)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-11-30

Study Completion Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will aid in ameliorating disease severity and disease duration.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Experimental and Clinical Studies of Retinal Stimulation

NCT03635645

Retinitis Pigmentosa

RECRUITING NA

Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

NCT01982383

Central Serous Chorioretinopathy

TERMINATED NA

Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198

NCT02226835

TERMINATED

Visual Cortex Stimulation in Patients With Amblyopia

NCT00097162

Amblyopia Anisometropic Ambyopia Amblyopia, Suppression

COMPLETED PHASE1

Improving Visual Field Deficits With Noninvasive Brain Stimulation

NCT05085210

Visual Field Defect, Peripheral Stroke Visual Impairment +6 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Serous Retinopathy (CSR)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eye Patching

Intervention

Group Type OTHER

Eye Patching

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eye Patching

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults 18 years of age and older
* Both males and females
* Patients diagnosed with active central serous retinopathy
* Patients who are willing to use an eye patch in the affected eye for 24 hours
* Patients who are able to make the follow up appointments as required by the study

Exclusion Criteria

* Individuals under 18 years of age
* Patients with vision less than 20/40 in the unaffected eye.
* Patients who are not able to undergo mfERG testing in a realiable manner.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No